Created at Source Raw Value Validated value
Oct. 26, 2020, 7:26 a.m. eu

[{"arm_notes": "New Type treatment : Gemtuzumab ozogamicin", "treatment_id": 541, "treatment_name": "Gemtuzumab ozogamicin", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Namilumab", "treatment_id": 1749, "treatment_name": "Namilumab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Infliximab", "treatment_id": 650, "treatment_name": "Infliximab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "", "treatment_id": 541, "treatment_name": "Gemtuzumab ozogamicin", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]